Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4156726

N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)Nc1ccc[n+](C(=O)Cc2ccccc2)c1.O=C([O-])C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.40
LTA4H P09960 3/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
FNTA P49354 2/20 0.33
FNTB P49356 2/20 0.33
PGGT1B P53609 2/20 0.33
METAP2 P50579 1/20 0.31
HDAC3 O15379 1/20 0.30
NCOR1 O75376 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC10 Q969S8 1/20 0.30
HDAC11 Q96DB2 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
HDAC9 Q9UKV0 1/20 0.30
HDAC5 Q9UQL6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4162710 0.87 CES1 (0.31) CES1HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4159142 0.87 CES1 (0.31) CES1HDAC1HDAC2
SCHEMBL4169033 0.75 CES1 (0.52) CES1HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4304781 0.73 CES1 (0.50) CES1HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL3502970 0.73 CES1 (0.35) CES1HDAC1HDAC2
SCHEMBL4156445 0.71 CES1 (0.59) CES1HDAC1HDAC2HDAC3HDAC4
SCHEMBL4605614 0.66 CES1 (0.45) CES1HDAC1HDAC2HDAC3HDAC4
SCHEMBL4166891 0.65 CES1 (0.52) CES1HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4304780 0.64 CES1 (0.50) CES1HDAC1HDAC2
SCHEMBL4171426 0.63 CES1 (0.44) CES1HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CES1 1925/4885LTA4H 2744/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.